RxDoctor Payments DataLook up a doctor →

Devon McKenzie, MD

Hematology & Oncology · Egg Harbor Township, NJNPI 1497152888

Payments from drug & device makers

$238,708in general payments, 2019–2025

Across 627 payments — averaging $380.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$121K
  • Sumitomo Pharma America, Inc.$108K
  • E.r. Squibb & Sons, L.L.C.$954
  • AstraZeneca$928
  • Novartis$752
  • Bristol Myers Squibb$572
  • plus $6K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer48$121,272
Sumitomo Pharma America, Inc.28$107,736
E.r. Squibb & Sons, L.L.C.47$954
AstraZeneca(2 entities)53$928
Novartis48$752
Bristol Myers Squibb37$572
Merck24$513
Astellas Pharma US Inc19$436
Johnson & Johnson23$372
Pharmacyclics LLC, An Abbvie Company16$343
Eisai Inc.19$317
Bayer18$310
Seagen Inc.21$299
Dendreon Pharmaceuticals LLC14$287
Gilead(2 entities)16$267
Genentech USA, Inc.18$267
Daiichi Sankyo Inc.16$257
Lilly USA, LLC12$235
GSK10$178
Incyte Corporation11$163
AbbVie10$161
Takeda Pharmaceuticals U.S.A., Inc.8$154
Genmab U.S., Inc.8$131
Taiho Oncology, Inc.8$121
Servier Pharmaceuticals LLC6$105
Mirati Therapeutics, Inc.6$104
AVEO Pharmaceuticals, Inc.4$98
Pharmacosmos Therapeutics Inc.6$97
Sobi, Inc6$91
Regeneron Healthcare Solutions, Inc.5$87
Tempus AI, Inc5$84
Medtronic1$77
Exelixis Inc.5$74
Array Biopharma Inc4$72
ADC Therapeutics America, Inc.3$60
Sanofi3$53
Beone Medicines USA, Inc.3$52
Geron Corporation3$51
Puma Biotechnology, Inc.3$51
Emmaus Medical, Inc.2$50
Stemline Therapeutics Inc.3$49
Amgen3$45
Beigene USA, Inc.3$45
Menarini Silicon Biosystems, Inc.2$43
Agios Pharmaceuticals, Inc.2$35
Boehringer Ingelheim2$31
Morphosys, US Inc.2$31
Myovant Sciences Inc.2$28
EMD Serono, Inc.1$19
Jazz Pharmaceuticals Inc.1$19
Spectrum Pharmaceuticals Inc.1$18
Karyopharm Therapeutics Inc.1$18
Dova Pharmaceuticals1$15
Foundation Medicine, Inc.1$15
Blueprint Medicines Corporation1$15
Legend Biotech USA Inc.1$14
Deciphera Pharmaceuticals Inc.1$14
Ipsen Biopharmaceuticals, Inc1$14
Recordati_rare_diseases_inc.1$14

How this compares

$238,708 in reported general payments places this provider in the 85th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$97,662
Medicare patients
356
Services billed
805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Egg Harbor Township

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →